Titre : Immunoglobuline A sécrétoire

Immunoglobuline A sécrétoire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Research Design
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Immunoglobuline A sécrétoire : Questions médicales les plus fréquentes", "headline": "Immunoglobuline A sécrétoire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Immunoglobuline A sécrétoire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-12", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Immunoglobuline A", "url": "https://questionsmedicales.fr/mesh/D007070", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A", "code": { "@type": "MedicalCode", "code": "D007070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026" } } }, "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire", "alternateName": "Immunoglobulin A, Secretory", "code": { "@type": "MedicalCode", "code": "D007071", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sonya Kumar Bharathkar", "url": "https://questionsmedicales.fr/author/Sonya%20Kumar%20Bharathkar", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, United States." } }, { "@type": "Person", "name": "Beth M Stadtmueller", "url": "https://questionsmedicales.fr/author/Beth%20M%20Stadtmueller", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, United States." } }, { "@type": "Person", "name": "Georgy A Nevinsky", "url": "https://questionsmedicales.fr/author/Georgy%20A%20Nevinsky", "affiliation": { "@type": "Organization", "name": "Institute of Chemical Biology and Fundamental Medicine, SD of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk 630090, Russia. Electronic address: nevinsky@niboch.nsc.ru." } }, { "@type": "Person", "name": "Nikit Kumar", "url": "https://questionsmedicales.fr/author/Nikit%20Kumar", "affiliation": { "@type": "Organization", "name": "Department of Structural Biology, Genentech, Inc., South San Francisco, CA, USA 94080." } }, { "@type": "Person", "name": "Christopher P Arthur", "url": "https://questionsmedicales.fr/author/Christopher%20P%20Arthur", "affiliation": { "@type": "Organization", "name": "Department of Structural Biology, Genentech, Inc., South San Francisco, CA, USA 94080." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39358688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-024-02342-y" } }, { "@type": "ScholarlyArticle", "name": "Implementing a combined Delphi and Focus Group qualitative methodology in Nexus research designs-The case of the WEFE Nexus in Apokoronas, Crete.", "datePublished": "2022-07-14", "url": "https://questionsmedicales.fr/article/35834515", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271443" } }, { "@type": "ScholarlyArticle", "name": "Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model.", "datePublished": "2023-04-21", "url": "https://questionsmedicales.fr/article/37081154", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10552-023-01699-7" } }, { "@type": "ScholarlyArticle", "name": "Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36823581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09166-4" } }, { "@type": "ScholarlyArticle", "name": "Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35668365", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-022-01642-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Globulines", "item": "https://questionsmedicales.fr/mesh/D005916" }, { "@type": "ListItem", "position": 5, "name": "Sérum-globulines", "item": "https://questionsmedicales.fr/mesh/D012712" }, { "@type": "ListItem", "position": 6, "name": "Immunoglobulines", "item": "https://questionsmedicales.fr/mesh/D007136" }, { "@type": "ListItem", "position": 7, "name": "Anticorps", "item": "https://questionsmedicales.fr/mesh/D000906" }, { "@type": "ListItem", "position": 8, "name": "Isotypes des immunoglobulines", "item": "https://questionsmedicales.fr/mesh/D007132" }, { "@type": "ListItem", "position": 9, "name": "Immunoglobuline A", "item": "https://questionsmedicales.fr/mesh/D007070" }, { "@type": "ListItem", "position": 10, "name": "Immunoglobuline A sécrétoire", "item": "https://questionsmedicales.fr/mesh/D007071" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Immunoglobuline A sécrétoire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Immunoglobuline A sécrétoire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Immunoglobuline A sécrétoire", "description": "Comment mesurer l'IgA sécrétoire ?\nQuels tests diagnostiques sont utilisés ?\nL'IgA sécrétoire est-elle liée à des maladies ?\nQuels symptômes peuvent indiquer un déficit d'IgA ?\nComment évaluer la fonction immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Immunoglobuline A sécrétoire", "description": "Quels symptômes sont associés à un déficit d'IgA ?\nL'IgA sécrétoire affecte-t-elle la digestion ?\nPeut-on avoir des symptômes respiratoires ?\nLes allergies sont-elles liées à l'IgA ?\nComment l'IgA sécrétoire influence-t-elle l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Immunoglobuline A sécrétoire", "description": "Comment prévenir les infections respiratoires ?\nL'alimentation influence-t-elle l'IgA ?\nLe stress affecte-t-il l'IgA ?\nLes probiotiques aident-ils l'IgA ?\nLes habitudes de vie influencent-elles l'IgA ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Immunoglobuline A sécrétoire", "description": "Comment traiter un déficit d'IgA ?\nDes suppléments d'IgA existent-ils ?\nLes vaccins sont-ils efficaces ?\nComment prévenir les infections ?\nY a-t-il des traitements alternatifs ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Immunoglobuline A sécrétoire", "description": "Quelles complications peuvent survenir avec un déficit d'IgA ?\nLe déficit d'IgA augmente-t-il le risque d'infections ?\nY a-t-il un lien avec les maladies auto-immunes ?\nLes allergies peuvent-elles s'aggraver ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Immunoglobuline A sécrétoire", "description": "Quels sont les facteurs de risque d'un déficit d'IgA ?\nL'âge influence-t-il l'IgA sécrétoire ?\nLe sexe joue-t-il un rôle ?\nLes infections virales affectent-elles l'IgA ?\nLe mode de vie influence-t-il l'IgA ?", "url": "https://questionsmedicales.fr/mesh/D007071?mesh_terms=Research+Design&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer l'IgA sécrétoire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'IgA sécrétoire est mesurée par des tests d'immunoessai sur des échantillons de mucus ou de salive." } }, { "@type": "Question", "name": "Quels tests diagnostiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et des analyses de fluides corporels sont utilisés pour évaluer l'IgA sécrétoire." } }, { "@type": "Question", "name": "L'IgA sécrétoire est-elle liée à des maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux d'IgA sécrétoire peuvent indiquer des maladies auto-immunes ou des infections." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un déficit d'IgA ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les infections récurrentes des voies respiratoires et digestives peuvent signaler un déficit d'IgA." } }, { "@type": "Question", "name": "Comment évaluer la fonction immunitaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'anticorps spécifiques et des évaluations cliniques sont utilisés pour évaluer la fonction immunitaire." } }, { "@type": "Question", "name": "Quels symptômes sont associés à un déficit d'IgA ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des infections fréquentes, des allergies et des problèmes digestifs." } }, { "@type": "Question", "name": "L'IgA sécrétoire affecte-t-elle la digestion ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible niveau d'IgA sécrétoire peut entraîner des troubles digestifs et des infections intestinales." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un déficit d'IgA sécrétoire peut provoquer des infections respiratoires fréquentes." } }, { "@type": "Question", "name": "Les allergies sont-elles liées à l'IgA ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un déséquilibre d'IgA sécrétoire peut contribuer à des réactions allergiques." } }, { "@type": "Question", "name": "Comment l'IgA sécrétoire influence-t-elle l'immunité ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'IgA sécrétoire joue un rôle clé dans la protection des muqueuses contre les agents pathogènes." } }, { "@type": "Question", "name": "Comment prévenir les infections respiratoires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, éviter les foules et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle l'IgA ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en nutriments peut soutenir la production d'IgA sécrétoire." } }, { "@type": "Question", "name": "Le stress affecte-t-il l'IgA ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut diminuer les niveaux d'IgA sécrétoire et affaiblir l'immunité." } }, { "@type": "Question", "name": "Les probiotiques aident-ils l'IgA ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les probiotiques peuvent aider à maintenir un équilibre immunitaire et soutenir l'IgA." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles l'IgA ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des habitudes de vie saines, comme l'exercice régulier, peuvent améliorer la fonction immunitaire." } }, { "@type": "Question", "name": "Comment traiter un déficit d'IgA ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des antibiotiques pour les infections et des immunoglobulines si nécessaire." } }, { "@type": "Question", "name": "Des suppléments d'IgA existent-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de suppléments d'IgA sécrétoire disponibles sur le marché pour le traitement." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins peuvent être moins efficaces chez les personnes avec un déficit d'IgA sécrétoire." } }, { "@type": "Question", "name": "Comment prévenir les infections ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène, des vaccinations et un suivi médical régulier aident à prévenir les infections." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs comme les probiotiques peuvent aider à renforcer l'immunité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un déficit d'IgA ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections récurrentes, des allergies et des maladies auto-immunes." } }, { "@type": "Question", "name": "Le déficit d'IgA augmente-t-il le risque d'infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec un déficit d'IgA sont plus susceptibles de développer des infections fréquentes." } }, { "@type": "Question", "name": "Y a-t-il un lien avec les maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un déficit d'IgA est associé à un risque accru de maladies auto-immunes comme la maladie cœliaque." } }, { "@type": "Question", "name": "Les allergies peuvent-elles s'aggraver ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec un déficit d'IgA peuvent développer des allergies plus sévères." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'un déficit d'IgA ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et des maladies auto-immunes." } }, { "@type": "Question", "name": "L'âge influence-t-il l'IgA sécrétoire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux d'IgA sécrétoire peuvent varier avec l'âge, souvent diminuant chez les personnes âgées." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent que les hommes peuvent être plus susceptibles d'avoir un déficit d'IgA." } }, { "@type": "Question", "name": "Les infections virales affectent-elles l'IgA ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent temporairement réduire les niveaux d'IgA sécrétoire." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il l'IgA ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain avec une bonne nutrition et de l'exercice peut soutenir l'IgA sécrétoire." } } ] } ] }

Sources (10000 au total)

Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials.

It is important to design clinical trials to include all those who may benefit from the intervention being tested. Several frameworks have been developed to help researchers think about the barriers t... Development of the STEP UP guidance had five phases: (1) Scoping literature review, (2) 'roundtable' discussion meetings, (3) redesign of trials, (4) interviews and (5) guidance document development, ... Over 40 experts contributed to the ACCESS project-patients and the public, clinicians, NHS research staff, trialists and other academics. The scoping review identified several strategies being used to... Researchers should consider inclusivity to shape initial trial design decisions. Trial teams and funders need to ensure that trials are given both the resources and time needed to implement the STEP U...

Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model.

Engagement of community participation is an innovative driver of modern research. However, to benefit the communities being studied, it is imperative to continuously evaluate ethical considerations, t...

Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review.

The provision of low-value physiotherapy services in low back pain management is a known but complex phenomenon. Thus, this scoping review aims to systematically map existing research designs and inst... The development of this review is guided by the analysis framework of Arksey and O'Malley. A two-stage, audited search strategy was performed in Medline (PubMed), Web of Science, and google scholar. A... Thirty-three articles met the inclusion criteria. Seventy-nine percent of articles focused on the appropriateness of physiotherapeutic treatments, followed by education and information (30%), the diag... Identified research on low-value physiotherapy care in low back pain management was widely unidimensional. Most articles focused on the effectiveness domain of care and investigated the provider persp... This review has been registered on open science framework ( https://osf.io/vzq7k https://doi.org/10.17605/OSF.IO/PMF2G )....

Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design.

Development of complex interventions for management of chronic conditions has become increasingly common, with guidance now provided. Fidelity (whether the intervention is designed, delivered and rece... Using the National Institute for Health Behaviour Change Consortium (NIH BCC) framework of fidelity, a set of enhancement strategies and a fidelity measurement strategy were developed with input from ... Hiring of respiratory professionals to the initial training programme was successful, with 44% of those expressing initial interest in being a Facilitator successfully completing the process. Video re... Addressing fidelity in complex intervention trials is a time and resource intensive process but has significant potential to increase understanding of results and strengthen the evidence base for effe... ISRCTN59537391 . Registered on 20 March 2017. Trial protocol version 6.0, 22 April 2018. Process evaluation protocol version 4.0, 1 November 2020....

A youth-centred approach to improving engagement in HIV services: human-centred design methods and outcomes in a research trial in Kisumu County, Kenya.

IntroductionInnovative interventions are needed to improve HIV outcomes among adolescents and young adults (AYAs) living with HIV. Engaging AYAs in intervention development could increase effectivenes... We applied an iterative, four-phased HCD process in Kenya that included: (1) systematic review of extant knowledge, (2) prioritisation of design challenges, (3) a co-creation workshop and (4) translat... Twenty-two participants engaged in the 4-day workshop. Co-creation activities yielded recommendations for improving planned interventions (eg, message frequency and content; strategies to engage hard-... Research employing HCD among youth can improve interventions preimplementation through empathy, youth-led inquiry and real-time problem solving. Peer navigation may be most influential in improving re...

Research designs and instruments to detect physiotherapy overuse of low-value care services in low back pain management: a scoping review protocol.

The provision of low-value care services in low back pain management is a problem of global scope. Inappropriate imaging, overmedication, and overused invasive therapies are prevalent in physician ser... The development of this scoping review is guided by the Arksey and O'Malley framework. A two-step, peer-reviewed search strategy in accordance with the PRESS checklist will be conducted on MEDLINE (Pu... Results of this scoping review will help researchers to systematically select overuse measures referring to aspects of the overuse typology, specific healthcare settings, and physiotherapy services. I... This protocol has been registered on the open science framework ( https://doi.org/10.17605/OSF.IO/PMF2G )....

Protocol for a meta-research study of protocols for diet or nutrition-related trials published in indexed journals: general aspects of study design, rationale and reporting limitations.

The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) reporting guideline establishes a minimum set of items to be reported in any randomised controlled trial (RCT) protocol.... We will conduct a meta-research study of RCT protocols published in journals indexed in at least one of six selected databases between 2012 and 2022. We have run a search in PubMed, Embase, CINAHL, We... This study will undertake a secondary analysis of published data and does not require ethical approval. The results will be disseminated through journals and conferences targeting stakeholders involve...

Qualitative longitudinal research in health research: a method study.

Qualitative longitudinal research (QLR) comprises qualitative studies, with repeated data collection, that focus on the temporality (e.g., time and change) of a phenomenon. The use of QLR is increasin... This method study used an adapted scoping review design. Articles were eligible if they were written in English, published between 2017 and 2019, and reported results from qualitative data collected a... A total of 299 articles were included. There was great variation among the articles in the use of methodological traditions, type of data, length of data collection, and components of longitudinal dat... QLR is often used in large complex studies. Some articles were thoroughly designed to capture time/change throughout the methodology, aim and data collection, while other articles included few element...